What’s new in pediatric bone sarcomas and benign bone tumors
Journal of Children's Orthopaedics · 2026-08 · 20 (4) · 359-370
DOI: 10.1177/18632521261444250 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Children's Orthopaedics, online erschienen am 27.04.2026. Verfasst von Nicolas von der Weid und 2 weiteren Autor:innen. Beteiligte Einrichtung: Pediatric Hematology-Oncology Department, University Children's Hospital and University of Basel, Basel, Switzerland. Die Arbeit nennt 75 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Significant progress has been made in the diagnosis and treatment of pediatric bone tumors in recent years. For malignant bone tumors, a better understanding of the molecular pathogenesis has been achieved, providing new directions for targeted approaches and immunotherapy. Advances in imaging techniques, such as whole-body magnetic resonance imaging and fluorodeoxyglucose-positron emission tomography/computed tomography, have improved the accuracy of staging, treatment response evaluation, and recurrence monitoring. In surgical treatment, 3D printing technology, computer navigation, and minimally invasive techniques have shifted the paradigm from resection to functional reconstruction. Technologies, including modular and expandable implants, along with bio-integrated prostheses, support long-term functional recovery in pediatric patients. For benign bone tumors, the use of targeted drugs like denosumab and the refinement of minimally invasive techniques such as cryotherapy and radiofrequency ablation have achieved a better balance between disease control and functional preservation. The ongoing development of multidisciplinary collaboration further optimizes personalized treatment strategies. Looking ahead, continuous progress in precision medicine will steer the diagnosis and treatment of pediatric bone tumors toward minimally invasive, individualized, and innovative approaches.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Pediatric Hematology-Oncology Department, University Children's Hospital and University of Basel, Basel, Switzerland.
- Bone and Soft Tissue Tumor Center of the University of Basel (KWUB), Basel, Switzerland.
- Bone Tumor Reference Center, University Hospital Basel, Basel, Switzerland.
- Basel Research Centre for Child Health (BRCCH), University of Basel and ETH Zurich, Basel, Switzerland.
- Department of Orthopedics, University Children's Hospital (UKBB), Basel, Switzerland.
ORCID-Profile: Nicolas von der Weid, Andreas H Krieg
Zitieren
APA
von der Weid, N., Baumhoer, D., & Krieg, A. H. (2026). What’s new in pediatric bone sarcomas and benign bone tumors. Journal of Children's Orthopaedics, 20(4), 359-370. https://doi.org/10.1177/18632521261444250
Vancouver
von der Weid N, Baumhoer D, Krieg AH. What’s new in pediatric bone sarcomas and benign bone tumors. Journal of Children's Orthopaedics. 2026;20(4):359-370. doi:10.1177/18632521261444250
BibTeX
@article{vonderWeid2026,
author = {von der Weid, Nicolas and Baumhoer, Daniel and Krieg, Andreas H},
title = {What’s new in pediatric bone sarcomas and benign bone tumors},
journal = {Journal of Children's Orthopaedics},
year = {2026},
volume = {20},
number = {4},
pages = {359--370},
doi = {10.1177/18632521261444250}
}
EUVIMED